日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial

在转移性去势抵抗性前列腺癌患者接受多西他赛和阿比特龙治疗后出现疾病进展的情况下,新型雄激素受体抑制剂氘代沙鲁胺的疗效:来自随机 III 期 HC-1119-04 试验的结果

Wu, Junlong; Li, Xinghai; Gu, Chengyuan; Hua, Lixin; Liu, Ranlu; Li, Jun; Qiu, Mingxing; Guo, Jianming; Dong, Haiying; Ji, Zhigang; Xie, Liping; Zhu, Shaoxing; Zhang, Xuhui; Chen, Peng; Jiang, Shusuan; Sun, Zhongquan; Xu, Danfeng; Chen, Hui; Shi, Benkang; Wang, Yujie; Pu, Jinxian; Perabo, Frank; Chen, Yuanwei; Ye, Dingwei

NSD2 targeting reverses plasticity and drug resistance in prostate cancer

NSD2靶向治疗可逆转前列腺癌的可塑性和耐药性

Li, Jia J; Vasciaveo, Alessandro; Karagiannis, Dimitris; Sun, Zhen; Gretarsson, Kristjan H; Chen, Xiao; Ouerfelli, Ouathek; Socciarelli, Fabio; Frankenstein, Ziv; Dong, Hanyang; Zou, Min; Yuan, Wei; Yang, Guangli; Aizenman, Gabriel M; Pannellini, Tania; Xu, Xinjing; Beltran, Himisha; Chen, Yu; Gardner, Kevin; Robinson, Brian D; de Bono, Johann; Gozani, Or; Abate-Shen, Cory; Rubin, Mark A; Loda, Massimo; Sawyers, Charles L; Califano, Andrea; Lu, Chao; Shen, Michael M

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

前列腺癌患者的试验设计和目标:前列腺癌工作组4的建议

Armstrong, Andrew J; Morris, Michael J; Abida, Wassim; Aggarwal, Rahul R; Antonarakis, Emmanuel S; Attard, Gerhardt; Beltran, Himisha; Bryce, Alan; Carducci, Michael A; Cheng, Heather H; Chen, Delphine L; Chi, Kim N; Childs, Daniel S; Dahut, William; Emmett, Louise; Fizazi, Karim; Gafita, Andrei; George, Daniel J; Hermann, Ken; Hofman, Michael S; Hope, Thomas; Hussain, Maha; Kelly, W Kevin; Kessler, Elizabeth; Kuo, Phillip H; Lang, Joshua; Liu, Glenn; Marshall, Catherine H; Morgans, Alicia K; McKay, Rana R; Nanus, David; Nelson, Peter; Paller, Channing; Reichert, Zachery R; Ryan, Charles J; Sartor, A Oliver; Schöder, Heiko; Schwartz, Lawrence H; Sharifi, Nima; Stadler, Walter M; Stein, Mark; Sternberg, Cora N; Szmulewitz, Russell Z; Tagawa, Scott T; Sokolova, Alexandra O; Wyatt, Alex W; Yamoah, Kosj; Yu, Evan Y; Halabi, Susan; Scher, Howard I

Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer

Alliance A222001:奥昔布宁与安慰剂治疗接受雄激素剥夺疗法治疗前列腺癌患者潮热的疗效比较

Stish, Bradley J; Mazza, Gina L; Nauseef, Jones T; Humeniuk, Michael Sandon; Smith, Thomas J; Tofthagen, Cindy; Diaz Pardo, Dayssy Alexandra; Chay, Christopher; Huang, Andrew J; Naha, Kushal; Tagawa, Scott T; Chow, Selina; Ruddy, Kathryn J; Lustberg, Maryam B; Adams-Campbell, Lucile L; Novotny, Paul J; Loprinzi, Charles L

Integrated single-cell and spatial transcriptomic profiling decodes lineage plasticity and immune microenvironment remodeling in prostate cancer progression.

整合单细胞和空间转录组分析揭示前列腺癌进展中的谱系可塑性和免疫微环境重塑。

Yu Hongyuan, Wang Yusong, He Mingcong, Chen Yiming, Bi Jianbin, Lin Xuyong, Cui Xiaolu

KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate/hnRNPA1 lactylation/AR-V7 axis.

KDM5B 驱动的葡萄糖代谢重编程通过乳酸/hnRNPA1 乳酸化/AR-V7 轴促进前列腺癌对恩扎卢胺的耐药性。

Sun Rui, Huang Yong, He Hao, Li Qiuchen, Wang Linfeng, Zhang Gaojie, Wei Ziling, Cao Yang, Li Jing, Wang Xianmin, Yang Fan, Chen Wenjun, Li Xiang, Yu Jiang, Liu Siyuan, Lei Congfeng, Jiang Yu, Peng Yueqiang, Su Huiyi, Gao Yingying, He Weiyang, Yang Lei, Liu Jiayu

Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming.

血清素通过表观遗传重编程调节神经内分泌前列腺癌的谱系可塑性。

Ji Yiyi, Ju Cheng-Wei, Chen Lei, Shen Kai, Su Ruopeng, Li Ang, Liu Xinyu, Liu Bo, Zhang Xinran, Lyu Ruitu, Xia Peng, Li Han, Pan Yiqian, Liu Yunzheng, Tse Man Hin, Xue Yizheng, Qian Hongyang, Jing Na, Zhu Helen He, Wang Liangliang, Zhang Li-Sheng, Jiang Shu-Heng, Zhang Weiwei, Dong Liang, Yan Zejun, Pan Jiahua, Zhu Yinjie, Wei Jiangbo, Wang Qi, Xue Wei

Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer.

治疗耐药性转移性前列腺癌中复发的免疫原性新抗原及其同源T细胞受体。

Gumpert Nofar, Sagie Shira, Arnedo-Pac Claudia, Babu Tomer, Weller Chen, Gonzalez-Perez Abel, Wang Yuan, Michel Todó Lucas, Levy Ronen, Chen Xi, Greenberg Polina, Dayan-Rubinov Maria, Yakubovich Elizabeta, Wasserman-Bartov Talya, Zerbib Mirie, Gong Jianhui, Rebernick Ryan J, Oliveira Tercero Anna, Agundez Muriel Laura, Benedek Gil, Kedmi Merav, Oren Roni, Ben-Dor Shifra, Levin Yishai, Troyanskaya Olga G, Munzur Aslı D, Wyatt Alexander W, Cieslik Marcin P, Quigley David A, Van Allen Eliezer M, Anandasabapathy Niroshana, Mateo Joaquin, Yang Xinbo, Martínez-Jiménez Francisco, Lopez-Bigas Nuria, Samuels Yardena

Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse models

胶原蛋白结合的IL-12修饰的STEAP1 CAR-T细胞可降低毒性并治疗小鼠模型中的前列腺癌

Sasaki, Koichi; Bhatia, Vipul; Asano, Yuta; Bakhtiari, Jakob; Kaur, Pooja; Wang, Chuyi; Matsuo, Takumi; Dubois, Olivier; Chiu, Po-Chuan; Gun, Donny; Singh, Charanjit; Panagi, Ioanna; Noblecourt, Laurine; Nikolaidi, Maria; Chong, Truman; Javier, Gerardo; Priceman, Saul J; Chapuis, Aude G; Lee, John K; Ishihara, Jun

Biomimetic bone niche reconstructs proliferation-inhibited and therapy-resistant bone-metastatic prostate cancer.

仿生骨微环境重建增殖受抑制和治疗耐药的骨转移性前列腺癌。

Chen Xin, Peng Yujiao, Zhao Ying, Liu Huiling, Lin Qijun, Fu Xihong, Chen Lianheng, Peng Zhongte, Huang Jianfeng, Luo Yu, Zou Xuenong, Yang Lei, Peng Xinsheng, Liu Chun